On April 25, Edwards Lifesciences posted better-than-expected results for its first quarter. The company said it sees FY24 adjusted EPS of $2.70 to $2.80 on revenue of $6.3 billion to $6.6 billion.

When asked about Freeport-McMoRan (NYSE:FCX), he said, “I want it to come in first, it's been straight up. I do not like parabolic moves.”

On April 23, Freeport-McMoRan reported first-quarter FY24 results. Revenue stood at $6.32 billion, beating the consensus of $5.66 billion. Adjusted EPS was 32 cents, beating the consensus of 27 cents.

On April 10, Delta Air Lines reported better-than-expected first-quarter earnings. Delta reported a first-quarter 2024 operating revenue growth of 8% year-over-year to $13.748 billion and adjusted operating revenue of $12.563 billion (+6% YoY), beating the consensus of $12.57 billion. Adjusted EPS was 45 cents, above the consensus of 36 cents, according to data from Benzinga Pro.

The Trade Desk, Inc. (NASDAQ:TTD) is doing “fantastically,” Cramer said. “Jeff Green [CEO of The Trade Desk] is doing a remarkable job, and lot of people prefer it to Google. So I will tell you that even though it's a very expensive stock, it is a good stock. And I would not sell it, I'm more inclined to buy it below the 80 level.”

On April 30, Roku, Inc. (NASDAQ:ROKU) announced plans for a new data-driven TV streaming partnership with Trade Desk to equip advertisers with better planning, buying, and measurement of TV streaming media.

Price Action:

• Edwards LifeSciences shares fell 1.5% to settle at $84.67 on Tuesday.
• Delta shares fell 0.8% to close at $50.07 on Tuesday.
• Freeport-McMoRan shares fell 4.7% to settle at $49.94 on Tuesday.
• Trade Desk shares fell 2% to settle at $82.85 during Tuesday's session.

Read Next: Top 4 Tech Stocks You May Want To Dump In Q2